- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06742112
The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals
December 16, 2024 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi
Validity and Reliability of the 6-minute Pegboard and Ring Test in Assessing Upper Extremity Function in Overweight and Obese Individuals
The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in overweight and obese individuals.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Merve Firat
- Phone Number: +90 850 441 02 44
- Email: mervefirat@ahievran.edu.tr
Study Locations
-
-
-
Kirsehir, Turkey
- Recruiting
- Kirşehir Ahi Evran University
-
Contact:
- Merve Firat
- Phone Number: +90 850 441 02 44
- Email: mervefirat@ahievran.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Overweight and obese individuals will be included in the study.
Description
Inclusion Criteria:
- Body mass index ≥ 25 kg/m2
- Volunteering for the study
Exclusion Criteria:
- Having uncontrolled hypertension, diabetes mellitus
- Having comorbidities that may affect physical functions
- Failure to cooperate with tests to be performed
- Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases
- Pregnancy
- Having a history of bariatric surgery
- Presence of contraindications to exercise testing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Overweight and obese individuals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle endurance
Time Frame: 1st day
|
30 second push-up test will be used, and total number will be recorded.
|
1st day
|
|
Arm exercise capacity
Time Frame: 1st day
|
It will be assessed by 6 minute pegboard and ring test.
|
1st day
|
|
Exercise capacity
Time Frame: 1st day
|
It will be assessed by 6 minute walk test.
|
1st day
|
|
Hand grip strength
Time Frame: 1st day
|
Will be measured using a hang grip dynamometer.
|
1st day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper extremity functional status
Time Frame: 1st day
|
Upper extremity functional status will be assessed with the Upper Extremity Functional Index.
This index consists of 20 questions, and the lowest possible score is 0 and the highest score is 80.
Higher scores indicate better functional status.
|
1st day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 11, 2024
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
December 16, 2024
First Submitted That Met QC Criteria
December 16, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 16, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-20/173
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.